Atara Biotherap
(ATRA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 31,779 | 39,754 | 51,615 | 0 | 0 |
| Marketable Securities | 24,719 | 22,277 | N/A | 0 | 0 |
| TOTAL | $57,085 | $62,291 | $51,808 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 11 | 8 | 8 | N/A | N/A |
| Other Non-Current Assets | 1,407 | 567 | 12 | 0 | 0 |
| TOTAL | $1,418 | $575 | $20 | $N/A | $N/A |
| Total Assets | $58,503 | $62,866 | $51,828 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 577 | 1,402 | 606 | 0 | 0 |
| Accrued Expenses | 359 | 199 | 331 | 0 | 0 |
| TOTAL | $2,101 | $2,788 | $1,524 | $0 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 183 | 210 | 230 | 0 | 0 |
| TOTAL | $183 | $210 | $230 | $N/A | $N/A |
| Total Liabilities | $2,284 | $2,998 | $1,754 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 776 | N/A | N/A | N/A | N/A |
| Common Shares | N/A | N/A | 1 | 0 | 0 |
| Retained earnings | -24,443 | -19,932 | -12,883 | 0 | 0 |
| Other shareholders' equity | 74,572 | 74,262 | 60,756 | 0 | 0 |
| TOTAL | $56,219 | $59,868 | $50,074 | $0 | $0 |
| Total Liabilities And Equity | $58,503 | $62,866 | $51,828 | $0 | $0 |